Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
Frontiers in Pharmacology · 31.01.2025 · 16
DOI: 10.3389/fphar.2025.1528604 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 31.01.2025. Verfasst von Ji-Ji Dao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology Department, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Neuronal senescence is a common pathological feature of various neurodegenerative diseases, with ferroptosis playing a significant role. This study aims to investigate the role of ErbB4 receptor activation in preventing D-Galactose (D-gal)-induced neuronal senescence.
Methods
Mice subjected to D-gal-induced aging were administered a small molecule ErbB4 receptor agonist (E4A), identified via virtual screening, melatonin, or a combination of both. Behavioral assessments were conducted to evaluate therapeutic efficacy in memory and cognitive functions. Immunofluorescence staining, western blot, and biochemical assays were primarily employed to assess changes in both senescence- and ferroptosis-related molecules in mouse hippocampal tissues in response to each treatment. Additionally, mouse hippocampal HT22 neuronal cell cultures were utilized to corroborate the in vivo findings.
Results
The targeted activation of ErbB4 receptor by E4A significantly ameliorated the behavioral deficits induced by D-gal in mice, demonstrating an effect comparable to that of melatonin, a natural inhibitor of in vivo senescence and ferroptosis. Both E4A and melatonin mitigated D-gal-induced aging in hippocampal neurons of mice. This was evidenced by the upregulation of Lamin B1 and the downregulation of P53, P21, P16, GFAP, and Iba-1 expression levels. Moreover, D-gal treatment markedly decreased the protein expression of the ferroptosis inhibitor Nrf2 while augmenting the expression of the ferroptosis promoter TFRC. These alterations were partially reversed by the individual administration of E4A and melatonin. In vitro studies further corroborated that D-gal treatment significantly and concurrently induced the expression of senescence markers and ferroptosis promoters. However, both E4A and melatonin were able to significantly reverse these changes. Additionally, E4A markedly ameliorated Erastin-induced ferroptosis in mouse hippocampal neuronal cells. Conlusion Our findings suggest that targeted activation of ErbB4 receptor may be a viable strategy for treating neuronal senescence by inhibiting ferroptosis, thereby offering a potential therapeutic avenue for senescence-associated neurodegenerative diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Biology Department, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
- MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
- Department of Pathogen Biology, Guizhou Nursing Vocational College, Guiyang, Guizhou, China.
- Laboratory of Neurodegenerative and Neuroinjury Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
- The First Affiliated Hospital, Department of Neurology, Multi-Omics Research Center for Brain Disorders, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
- Clinical Research Center for Immune-Related Encephalopathy in Hunan Province, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Zitieren
APA
Dao, J. J., Zhang, W., Liu, C., Li, Q., Qiao, C. M., Cui, C., Shen, Y. Q., Chen, S. X., & Zhao, W. J. (2025). Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1528604
Vancouver
Dao JJ, Zhang W, Liu C, Li Q, Qiao CM, Cui C, et al. Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1528604
BibTeX
@article{Dao2025,
author = {Dao, Ji-Ji and Zhang, Wei and Liu, Chong and Li, Qian and Qiao, Chen-Meng and Cui, Chun and Shen, Yan-Qin and Chen, Shuang-Xi and Zhao, Wei-Jiang},
title = {Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1528604}
}
EUVIMED